We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRDO:NASDAQCredo Technology Group Holding Ltd Analysis

Data as of 2026-08-09 - not real-time

$249.89

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Credo Technology Group Holding Ltd trades at $249.89, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has lost 6.8% over the past 30 days. Relative strength is 57.0 — neutral — and the MACD signal is bullish. Price has been bracketed by support at $177.00 and resistance at $252.81.
Valuation screens as overvalued: a P/E of 100.0 sits above the sector average of 36.1. Analyst price targets sit 11.8% above the current price. Revenue is growing at 157.0% on a 35.4% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 108.5%, a beta of 3.32 and a maximum drawdown of 53.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top Market Events

It has been about a month since the last earnings report for Credo Technology Group Holding Ltd.Credo Technology Group Holding Ltd. NASDAQ:CRDO is one of BlackRock’s 30 most important AI stocks right now....Polen Capital, an investment management company, released its second-quarter 2026 investor letter for “Polen...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 168.39
  • MACD momentum is positive
  • 30-day price change of -6.8%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 100.0 versus sector average of 36.1
  • Trading above the 200-day average of 168.39
  • Analyst targets imply +11.8% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 100.0 versus sector average of 36.1
  • Analyst targets imply +11.8% versus the current price
  • Profit margin of 35.4% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth157.00%
Profit Margin35.37%
P/E Ratio100.0
ROE34.41%
ROA17.92%
Debt/Equity1.23
P/B Ratio22.5
Op. Cash Flow$464.3M
Free Cash Flow$250.8M
Industry P/E36.1

Technical Analysis

TrendNeutral
RSI57.0
Support$177.00
Resistance$252.81
MA 20$218.57
MA 50$236.32
MA 200$168.39
MACDBullish
VolumeStable
Fear & Greed Index94.82

Valuation

Fair Value$54.58
Target Price$279.29
Upside/Downside11.76%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta3.32
Volatility108.51%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.